WA-KYMETA
17.5.2023 07:01:29 CEST | Business Wire | Press release
Kymeta (www.kymetacorp.com), a world leading flat panel satellite antenna company, today announced at CABSAT 2023 that telecom service provider Azyan Telecom (azyansat.om) signed a significant order for its Hawk™ u8 terminals connected by OneWeb, bringing Kymeta and OneWeb’s one-of-a kind LEO (Low Earth Orbit) offering to Oman for the first time. The deal will enable expansion of national telecom capabilities in the region, expediting efforts to implement ubiquitous high-speed, low-latency communications capabilities across the Sultanate.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230516006010/en/
Ahmed Saber, Chief Operating Officer, Azyan Telecom and Thomas Thorne, Regional Vice President, Europe & Middle East, Kymeta. (Photo: Business Wire)
Uniquely enabled by a software-first approach, Kymeta’s electronically steered flat panel Hawk u8 will help deliver reliable, truly mobile broadband connectivity across sectors in Oman connected via OneWeb’s LEO satellite constellation, including in areas where challenging terrain and frequent hurricanes often hinder high-speed connectivity offerings. The deal follows closely on the heels of Kymeta’s announcement that the Hawk u8 is now commercially available worldwide.
“As access to mobile broadband becomes increasingly imperative for progress across every major industry, Kymeta has doubled down on our commitment to deliver truly mobile connectivity to customers around the world,” said Walter Berger, President and Co-CEO, Kymeta. “We are invigorated by the opportunity to deliver our solutions to the Sultanate of Oman alongside Azyan Telecom, which we see as an emblematic step forward as we continue to expand our partnerships in the region.”
Ahmed Saber, Chief Operation Officer, Azyan Telecom added, “Today marks an exciting milestone, both for the growth of Oman’s LEO market and our efforts to enhance high-speed satellite connectivity for companies and communities across the region. Our deal with Kymeta will allow us to deliver on the widespread demand for reliable connectivity, in line with Oman's digital transformation strategy. We are thrilled at the opportunity to expand upon our offerings in support of industries across Oman and grateful for the continued support of the Telecommunication Regulatory Authority.”
Widely adopted by military, government, and enterprise customers, Kymeta offers the world’s only high-bandwidth, low-power, fully integrated family of high throughput mobile terminals. With the Hawk u8 LEO terminal, Kymeta customers can access OneWeb’s high-speed, low-latency broadband connectivity services while on the move or stationary as these services continues to be rolled out across the world.
The terminals will be available for delivery to the Omani market in Q1, 2024. For more information, direct inquiries to Kymeta and Azyan Telecom’s contacts, listed below.
About Kymeta
Kymeta is the industry leader in flat panel satellite antennas, providing purpose-built solutions across a variety of enterprise and military applications and unlocking the commercial value of space to address the vast, unmet demand for ubiquitous broadband and truly mobile connectivity for customers around the world. Its innovative metasurface technology, coupled with a software-first approach, delivers the first commercially available, metamaterial-based and electronically steered flat panel satellite antenna. Kymeta’s low-cost, low-power and high throughput solutions make it easy to connect on the move or while stationary – for any vehicle, vessel, aircraft, or fixed platform – enabling industries on earth to transform their operations by harnessing capacity in space.
Kymeta is a privately held company based in Redmond, Washington.
For more information, visit kymetacorp.com.
About Azyan Telecom
Azyan Telecom, a fully owned Omani entity, is the first licensed VSAT service provider with expertise in VSAT connectivity, network consultancy and support in the Sultanate of Oman with its earth station being in Muscat, Oman. Azyan Telecom has a very strong satellite footprint in Oman and can provide VSAT Connectivity to the entire country including remote and rural areas. Azyan Telecom delivers reliable, near real-time, mission-critical communications services and creates the vital lines of communication that help improve lives, build businesses, and develop new opportunities.
Azyan Telecom is a leading provider of business-critical Telecommunication and managed services in the Sultanate of Oman. As one of the top satellite companies in the region Azyan Telecom provides High Quality communication with reliable Satellite Services. Find out more at http://www.azyansat.om.
About OneWeb:
OneWeb is a global communications network powered from space, enabling connectivity for governments, businesses, and communities. It is implementing a constellation of low Earth orbit (LEO) satellites with a network of global gateway stations and a range of user terminals to provide an affordable, fast, high-bandwidth and low-latency communications service, connected to the IoT future and a pathway to 5G.
Find out more at http://www.oneweb.world.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20230516006010/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Galderma Receives U.S. FDA Approval for Differin® Epiduo® Acne Gel Prescription-to-OTC Switch22.5.2026 18:25:00 CEST | Press release
A unique Prescription-to-OTC switch in acne care, this approval expands access to a dermatologist-trusted, prescription-strength treatment for millions of acne sufferers ages 12 years and older Backed by more than 15 years of real-world dermatologist use and a robust clinical research program, this milestone demonstrates the depth of science behind the Differin® and Epiduo® heritage Adapalene plus benzoyl peroxide (0.1/2.5%) was the first FDA-approved, stable, fixed- dose prescription acne treatment to combine of benzoyl peroxide with a retinoid, and is now available over-the-counter The formulation is engineered to target multiple causes of acne more effectively than either of its individual active ingredients alone Galderma (SIX: GALD), the pure-play dermatology category leader, today announced that the United States (U.S.) Food and Drug Administration (FDA) has approved Differin® Epiduo® Acne Gel (Adapalene 0.1% and Benzoyl Peroxide 2.5% Acne Treatment) for over-the-counter (OTC) us
Avanzanite Bioscience’s Partner Agios Announces PYRUKYND® (mitapivat) Approval in the European Union for Adults with Thalassaemia22.5.2026 16:18:00 CEST | Press release
Avanzanite will commercialise and distribute PYRUKYND in Europe under its exclusive agreement with Agios Avanzanite is committed to collaborating with local authorities in the EU to enable access to PYRUKYND for adult patients with thalassaemia Avanzanite Bioscience B.V., a rapidly growing commercial-stage European specialty pharmaceutical company focused on rare diseases, today reported that its partner, Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a commercial-stage biopharmaceutical company headquartered in Cambridge, Massachusetts focused on delivering innovative medicines for patients with rare diseases, announced that the European Commission has granted marketing authorisation for PYRUKYND® (mitapivat), an oral pyruvate kinase (PK) activator, in adults for the treatment of anaemia associated with transfusion-dependent and non-transfusion-dependent alpha- or beta-thalassaemia, with an orphan medicinal product designation. This press release features multimedia. View the full releas
ICE Brent and ICE WTI Perpetual Futures to Launch on OKX22.5.2026 14:30:00 CEST | Press release
OKX, a blockchain technology and trading company serving more than 120 million customers globally,and Intercontinental Exchange (NYSE: ICE), one of the world's leading providers of financial market technology and data powering global capital markets including the New York Stock Exchange, today announced plans for OKX to launch perpetual futures based on ICE's Brent Crude and WTI Crude energy benchmarks. The products are expected to be available to trade on OKX’s platform in jurisdictions where OKX is licensed to offer perpetual futures products. The new OKX contracts represent a major step forward in expanding regulated access to global commodity markets through digital asset infrastructure. This first product collaboration between OKX and ICE comes after the companies established a strategic relationship in March 2026. ICE operates some of the world’s leading exchanges, clearing houses and market data services across energy, commodities, fixed income and equities markets. ICE’s future
Enhertu® Recommended for Approval in the EU by CHMP for Patients with Previously Treated HER2 Positive Metastatic Solid Tumors22.5.2026 14:00:00 CEST | Press release
Enhertu® (trastuzumab deruxtecan) has been recommended for approval in the European Union (EU) as a monotherapy for the treatment of adult patients with unresectable or metastatic HER2 positive (immunohistochemistry [IHC] 3+) solid tumors who have received prior treatment and who have no satisfactory treatment options. Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from patients with HER2 positive (IHC 3+) tumors in three phase 2 trials including DESTINY-PanTumor02,DESTINY-Lung01 andDESTINY-CRC02 where Enhertu demonstrated clinically meaningful responses across a broad range of tumors. The recommendation will now be reviewed by the European Commission, which has the authority
Future Health Challenge Awards USD 300,000 to Early Detection and Population Health Sensing Tools on Sidelines of World Health Assembly22.5.2026 13:45:00 CEST | Press release
Global teams recognised in the Future Health Challenge for solutions designed to detect health risks earlier and support faster health system decisions Future Health – A Global Initiative by Abu Dhabi and MIT Solve announce the winners of the inaugural Future Health ChallengeWinning solution equips frontline health workers in low-resource settings with mobile clinical decision-support tools, enabling earlier detection and more effective care deliveryTeams competed for a USD 200,000 grand prize and two USD 50,000 runner-up awards on the sidelines of the 79th World Health Assembly in GenevaWinners recognised for solutions advancing anticipatory, data-driven health systems Three global teams developing early detection and real-time population health monitoring solutions have secured a total of USD 300,000 on the sidelines of the 79th World Health Assembly. The winning solutions address critical challenges in early detection, continuous population insight and more timely decision making, s
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom